Johns Hopkins Magazine -- February 1999
Johns Hopkins 
     Magazine Home

FEBRUARY 1999
CONTENTS

RETURN TO
Rx AGAINST TERROR

AUTHOR'S NOTEBOOK

RELATED SITES

P U B L I C    P O L I C Y    A N D    I N T E R N A T I O N A L
A F F A I R S

The Deadliest Five
Cell Photos Courtesy
Centers for Disease Control and Prevention
and U.S. Army Military Research Institute of Infectious Diseases

   Description Symptoms Fatality Rate Treatment

(Inhalational) Anthrax
Bacillus anthracis
Inhaled spores germinate and release toxins, causing swelling in chest cavity. Possible blood and brain infection. Fever, fatigue, and malaise, starting within two to 46 days; progresses to chest pain, cough, rapid deterioration of health. Kills more than 85 percent of those it infects, often within one to three days after symptoms appear. Antibiotics (preferably ciprofloxacin) should be given before symptoms appear. Vaccine available, though not to civilians.

Smallpox
Variola Virus
Very contagious, airborne disease. About 12 to 14 days after infection. Fever, aches, vomiting, rash of small red spots that grow into larger, painful pustules covering the body. Fatal in 30 percent of unvaccinated patients. No treatment. U.S. has vaccine for about 6 million people. Only a fraction of those vaccinated before 1972 still protected.

(Pneumonic) Plague
Yersinia Pestis
Natural, flea-borne form causes bubonic plague. Gravest threat is posed by aerosol, leading to pneumonic plague. High fever, headache, and bloody cough; progresses to labored breathing, bluish-grayish skin color, respiratory failure and death. If untreated, a person with pneumonic plague will almost always die within one to two days after symptoms begin. Various antibiotics including streptomycin and gentamicin. Isolate patients.

Viral Hemorrhagic Fever
Highly infectious RNA viruses including Ebola, Marburg, Lassa, and dengue fever. Spread by rodents, ticks, mosquitoes. Vary from one type of HFV to the next. include fever, muscle aches, exhaustion, internal bleeding. Varies. Death rate from dengue is as low as 1 percent. Ebola fatality rates have reached 90 percent. Mainly supportive therapy. Anti-viral drug ribavirin useful in treating some viruses but not others (Ebola, Marburg).

(Inhalational) Botulism
Clostridium botulinum)
Produces toxin that blocks nerve signals, inhibits muscle movement. Weapon would most likely aerosolize toxin. Difficulty swallowing food, mental numbness, muscle paralysis, possible breathing failure. Inhalational form: Difficult to say since only a handful of cases have been recorded. Patients with respiratory paralysis should be placed on ventilator. Antitoxin given early may prevent progression.


RETURN TO FEBRUARY 1999 TABLE OF CONTENTS.